3SBio Stock | 1530.HK | KYG8875G1029 | A14T7Q

Date	3SBio Price
9/16/2024	5.20 undefined
9/13/2024	5.13 undefined
9/12/2024	5.10 undefined
9/11/2024	5.13 undefined
9/10/2024	5.12 undefined
9/9/2024	5.26 undefined
9/5/2024	5.32 undefined
9/4/2024	5.29 undefined
9/3/2024	5.35 undefined
9/2/2024	5.38 undefined
8/30/2024	5.51 undefined
8/29/2024	5.50 undefined
8/28/2024	5.37 undefined
8/27/2024	5.39 undefined
8/26/2024	5.33 undefined
8/23/2024	5.23 undefined
8/22/2024	5.87 undefined
8/21/2024	5.89 undefined
8/20/2024	5.90 undefined
8/19/2024	5.96 undefined

Date	3SBio Revenue	3SBio EBIT	3SBio Net Income
2029e	13.32 B undefined	0 undefined	0 undefined
2028e	12.38 B undefined	0 undefined	0 undefined
2027e	10.82 B undefined	2.59 B undefined	1.37 B undefined
2026e	10.5 B undefined	3.06 B undefined	2.24 B undefined
2025e	9.66 B undefined	2.81 B undefined	2.12 B undefined
2024e	8.92 B undefined	2.62 B undefined	1.95 B undefined
2023	7.82 B undefined	2.45 B undefined	1.55 B undefined
2022	6.87 B undefined	2 B undefined	1.92 B undefined
2021	6.38 B undefined	1.76 B undefined	1.65 B undefined
2020	5.59 B undefined	1.43 B undefined	835.79 M undefined
2019	5.32 B undefined	1.22 B undefined	973.72 M undefined
2018	4.58 B undefined	1.3 B undefined	1.28 B undefined
2017	3.73 B undefined	1.17 B undefined	935.39 M undefined
2016	2.8 B undefined	918.81 M undefined	712.56 M undefined
2015	1.67 B undefined	464.35 M undefined	526.28 M undefined
2014	1.13 B undefined	356.11 M undefined	291.73 M undefined
2013	875.4 M undefined	193.8 M undefined	95.9 M undefined
2012	669.9 M undefined	128.8 M undefined	102.4 M undefined
2011	541.6 M undefined	121.6 M undefined	108.6 M undefined
2010	418.6 M undefined	88.1 M undefined	81.3 M undefined
2009	316.9 M undefined	85 M undefined	83.4 M undefined
2008	243.2 M undefined	48.2 M undefined	39.5 M undefined
2007	180.2 M undefined	49.6 M undefined	81.5 M undefined
2006	127.8 M undefined	39.7 M undefined	30.5 M undefined
2005	102 M undefined	23.9 M undefined	16.1 M undefined
2004	77.2 M undefined	12.6 M undefined	6.6 M undefined

	Revenue	EBIT	Net Income
2004	77.2 M CNY	12.6 M CNY	6.6 M CNY
2005	102 M CNY	23.9 M CNY	16.1 M CNY
2006	127.8 M CNY	39.7 M CNY	30.5 M CNY
2007	180.2 M CNY	49.6 M CNY	81.5 M CNY
2008	243.2 M CNY	48.2 M CNY	39.5 M CNY
2009	316.9 M CNY	85 M CNY	83.4 M CNY
2010	418.6 M CNY	88.1 M CNY	81.3 M CNY
2011	541.6 M CNY	121.6 M CNY	108.6 M CNY
2012	669.9 M CNY	128.8 M CNY	102.4 M CNY
2013	875.4 M CNY	193.8 M CNY	95.9 M CNY
2014	1.13 B CNY	356.11 M CNY	291.73 M CNY
2015	1.67 B CNY	464.35 M CNY	526.28 M CNY
2016	2.8 B CNY	918.81 M CNY	712.56 M CNY
2017	3.73 B CNY	1.17 B CNY	935.39 M CNY
2018	4.58 B CNY	1.3 B CNY	1.28 B CNY
2019	5.32 B CNY	1.22 B CNY	973.72 M CNY
2020	5.59 B CNY	1.43 B CNY	835.79 M CNY
2021	6.38 B CNY	1.76 B CNY	1.65 B CNY
2022	6.87 B CNY	2 B CNY	1.92 B CNY
2023	7.82 B CNY	2.45 B CNY	1.55 B CNY
2024e	8.92 B CNY	2.62 B CNY	1.95 B CNY
2025e	9.66 B CNY	2.81 B CNY	2.12 B CNY
2026e	10.5 B CNY	3.06 B CNY	2.24 B CNY
2027e	10.82 B CNY	2.59 B CNY	1.37 B CNY
2028e	12.38 B CNY	0 CNY	0 CNY
2029e	13.32 B CNY	0 CNY	0 CNY

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.02	0.03	0.03	0.81	0.73	0.73	0.58	0.77	0.88	0.53	0.16	1.9	1.04	3.1	1.86	2.56	4.36	4.77	7.01	5.99
0.06	0.05	0.04	0.06	0.05	0.06	0.08	0.11	0.12	0.14	0.22	0.41	0.68	1.19	1.35	0.93	0.86	1.29	1.22	1.01
4	6	12	11	32	35	90	66	84	98	191.41	273.75	227.45	568.59	794.34	533.89	674.66	577.48	92.56	400.65
9	6	9	7	8	15	22	28	35	50	100.4	134.39	262.44	376.53	384.61	528.47	619.51	690.52	712.74	777.54
0	0	0.01	0.01	0	0.02	0.02	0.02	0.01	0.11	0.26	0.04	0.03	0.04	0.05	0.05	0.16	0.47	0.71	1.01
0.1	0.1	0.09	0.89	0.83	0.85	0.79	0.99	1.12	0.93	0.94	2.76	2.24	5.28	4.44	4.6	6.68	7.79	9.75	9.19
0.05	0.04	0.04	0.05	0.08	0.17	0.2	0.2	0.23	0.25	0.38	0.46	1.8	1.76	1.79	2.32	2.98	3.83	4.5	5.15
0	0	0	0.02	0.04	0.02	0.14	0.05	0.05	0	0.24	1.73	0.14	0.08	0.7	1.28	1.65	1.32	1.38	3.13
0	0	0	0	0	0	3	3	2	1	0.35	0	79.52	35.37	28.76	6.56	2.2	0	0	0
0	0.01	0.01	0.01	0.01	0.01	0.05	0.07	0.06	0.04	0.41	0.5	2.29	2.25	2.3	2.17	1.9	1.85	1.58	1.55
0	0	0	0	0	0	0	0	0	0	0.23	0.56	4.13	3.92	4.09	4.15	3.92	3.84	4.14	4.2
3	2	1	2	1	2	0	0	24	44	116.97	615.9	367.38	422.76	492.01	292.93	544.91	579.31	657.76	391.96
0.05	0.05	0.05	0.08	0.13	0.2	0.39	0.32	0.36	0.34	1.36	3.87	8.8	8.48	9.4	10.21	11	11.42	12.26	14.43
0.15	0.15	0.14	0.97	0.95	1.05	1.19	1.31	1.48	1.27	2.31	6.63	11.04	13.75	13.84	14.81	17.68	19.21	22.01	23.63

63	63	0	0	0	0	0	0	0	0	0	0.15	0.16	0.16	0.16	0.16	0.16	0.16	0.15	0.15
0.02	0.02	0.08	0.92	0.91	0.92	0.95	0.97	0.99	0.64	0.52	4.55	4.55	4.57	4.59	4.55	4.65	4.49	4.04	3.81
-0.05	-0.04	-0.01	0.07	0.11	0.2	0.28	0.39	0.53	0.59	0.58	1.1	1.82	2.75	3.89	4.87	5.7	7.53	8.99	10.53
1	2	0	-48	-102	-101	-111	-122	-159	-161	-168.67	-33.78	158.82	81.06	174.6	202.33	142.15	104.1	175.88	79.46
0	0	0	0	0	1	22	-5	5	7	6.53	1.7	0.06	-4.39	0.16	1.05	197.09	98.38	-35.5	-151.57
0.03	0.04	0.07	0.94	0.92	1.01	1.14	1.23	1.37	1.07	0.93	5.62	6.52	7.4	8.66	9.63	10.69	12.23	13.16	14.27
1	1	2	2	2	3	5	6	4	7	25.64	34.44	58.79	274.57	112.92	149.76	203.29	230.41	249.52	212.06
11	11	16	22	25	27	32	42	0	0	0	0	334.9	459.06	618.05	636.45	496.48	643.4	742.78	994
1	1	2	1	2	8	11	15	81	83	608.82	333.17	231.47	374.72	354.25	336.09	383.99	385.43	426.11	400.21
71	91	19	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0.62	0.41	0.52	1.09	0.57	0.49	0.37	0.16	0.43	2.12
0.08	0.1	0.04	0.03	0.03	0.04	0.05	0.06	0.09	0.09	1.25	0.77	1.14	2.2	1.66	1.61	1.45	1.42	1.84	3.73
0.03	0	0.03	0	0	0	0	0	0	0	0	0	2.54	3.32	2.72	2.32	2.55	2.47	4.09	2.72
0	0	0	0	0	0	0	0	0	65	73.62	81.79	294.4	280.27	270.76	268.08	272.24	264.47	279.87	250.55
6	5	4	4	4	3	2	2	13	32	37.34	140.57	293.76	328.58	281.64	248.18	314.74	402.2	428.54	416.76
0.04	0.01	0.03	0	0	0	0	0	0.01	0.1	0.11	0.22	3.13	3.93	3.28	2.84	3.13	3.13	4.8	3.38
0.12	0.11	0.07	0.03	0.03	0.04	0.05	0.07	0.1	0.19	1.36	0.99	4.27	6.12	4.93	4.45	4.58	4.55	6.65	7.11
0.15	0.15	0.14	0.97	0.95	1.05	1.19	1.3	1.47	1.26	2.3	6.62	10.79	13.52	13.59	14.08	15.27	16.78	19.81	21.38

2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0.01	0.02	0.03	0.08	0.04	0.08	0.08	0.11	0.13	0.21	0.36	0.59	0.85	1.1	1.5	1.22	0.98	1.87	2.27
7	8	8	5	4	6	8	15	22	30	40	33	77	161	243	313	333	360	329	366
1,000	0	1,000	1,000	0	1,000	-1,000	1,000	0	0	0	0	0	0	0	0	0	0	0	0
-23	-6	0	-1	-18	-12	-8	-63	-16	-35	-120	-107	-124	-118	-376	-506	-10	-555	-619	-276
-1	-1	-1	1	1	25	7	24	22	19	89	100	-85	111	104	-152	341	560	0	-183
5	6	5	4	0	0	0	0	0	0	0	28	25	131	125	66	38	196	6	45
0	0	0	2	5	8	12	20	21	35	49	133	65	122	130	263	355	254	286	346
-0.02	0.01	0.02	0.04	0.07	0.06	0.09	0.06	0.14	0.14	0.22	0.39	0.46	1	1.07	1.15	1.89	1.34	1.58	2.18
-2	0	-9	-2	-17	-42	-95	-82	-52	-54	-50	-25	-97	-466	-259	-462	-486	-981	-1,145	-973
-24	2	-9	17	-36	-368	-266	-165	-52	-201	481	-289	-3,248	-4,381	-643	-405	-1,133	-1,869	-1,286	-3,721
-21	3	0	19	-19	-326	-170	-83	0	-147	531	-263	-3,150	-3,914	-383	56	-647	-888	-140	-2,748
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.03	0	-0.01	-0.05	-0.04	0	0	0	0	0	0	0.59	-0.28	2.52	1.49	-1.19	-0.52	0.03	-0.11	1.63
0	0	0	0	0.92	-0.01	0	0.01	0	0	0	0	4.13	0	0	-0.04	-0.03	-0.01	-0.41	-0.48
0.03	0	-0.01	-0.05	0.8	-0.01	0	0.01	0.02	0	-0.59	-0.25	3.87	2.71	1.32	-1.39	-0.45	1.55	-0.48	0.71
0	0	0	-0.01	-0.08	0	0	0	0.01	0	-0.59	-0.84	0.02	0.19	-0.17	-0.01	0.11	1.53	0.04	-0.03
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-150	-16	0	0	-417
-0.01	0.01	0.01	0	0.79	-0.37	-0.18	-0.11	0.09	-0.06	0.11	-0.16	1.19	-0.62	1.72	-0.61	0.29	1.01	-0.22	-0.72
-18.9	6.3	15.6	34.3	51.5	18.2	-7.2	-24	84.3	90.3	167.3	360.66	357.75	538.29	814.86	687.86	1,401.13	363.09	432.57	1,206.54
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

3SBio Gross margin	3SBio Profit margin	3SBio EBIT margin	3SBio Profit margin
2029e	84.98 %	0 %	0 %
2028e	84.98 %	0 %	0 %
2027e	84.98 %	23.94 %	12.64 %
2026e	84.98 %	29.09 %	21.29 %
2025e	84.98 %	29.09 %	21.9 %
2024e	84.98 %	29.42 %	21.81 %
2023	84.98 %	31.37 %	19.82 %
2022	82.61 %	29.13 %	27.9 %
2021	82.67 %	27.61 %	25.87 %
2020	80.98 %	25.55 %	14.96 %
2019	82.6 %	22.85 %	18.31 %
2018	80.86 %	28.44 %	27.86 %
2017	81.89 %	31.34 %	25.05 %
2016	85.62 %	32.85 %	25.47 %
2015	85.54 %	27.75 %	31.45 %
2014	92.26 %	31.49 %	25.8 %
2013	90.5 %	22.14 %	10.95 %
2012	89.48 %	19.23 %	15.29 %
2011	89.27 %	22.45 %	20.05 %
2010	90.04 %	21.05 %	19.42 %
2009	92.05 %	26.82 %	26.32 %
2008	91.08 %	19.82 %	16.24 %
2007	90.34 %	27.52 %	45.23 %
2006	90.92 %	31.06 %	23.87 %
2005	84.8 %	23.43 %	15.78 %
2004	80.57 %	16.32 %	8.55 %

	Gross margin	EBIT margin	Profit margin
2004	80.57 %	16.32 %	8.55 %
2005	84.8 %	23.43 %	15.78 %
2006	90.92 %	31.06 %	23.87 %
2007	90.34 %	27.52 %	45.23 %
2008	91.08 %	19.82 %	16.24 %
2009	92.05 %	26.82 %	26.32 %
2010	90.04 %	21.05 %	19.42 %
2011	89.27 %	22.45 %	20.05 %
2012	89.48 %	19.23 %	15.29 %
2013	90.5 %	22.14 %	10.95 %
2014	92.26 %	31.49 %	25.8 %
2015	85.54 %	27.75 %	31.45 %
2016	85.62 %	32.85 %	25.47 %
2017	81.89 %	31.34 %	25.05 %
2018	80.86 %	28.44 %	27.86 %
2019	82.6 %	22.85 %	18.31 %
2020	80.98 %	25.55 %	14.96 %
2021	82.67 %	27.61 %	25.87 %
2022	82.61 %	29.13 %	27.9 %
2023	84.98 %	31.37 %	19.82 %
2024e	84.98 %	29.42 %	21.81 %
2025e	84.98 %	29.09 %	21.9 %
2026e	84.98 %	29.09 %	21.29 %
2027e	84.98 %	23.94 %	12.64 %
2028e	84.98 %	0 %	0 %
2029e	84.98 %	0 %	0 %

Date	3SBio Sales per Share	3SBio EBIT per share	3SBio Earnings per Share
2029e	5.61 undefined	0 undefined	0 undefined
2028e	5.21 undefined	0 undefined	0 undefined
2027e	4.55 undefined	0 undefined	0.58 undefined
2026e	4.42 undefined	0 undefined	0.94 undefined
2025e	4.06 undefined	0 undefined	0.89 undefined
2024e	3.75 undefined	0 undefined	0.82 undefined
2023	3.2 undefined	1 undefined	0.63 undefined
2022	2.59 undefined	0.76 undefined	0.72 undefined
2021	2.3 undefined	0.64 undefined	0.6 undefined
2020	2.03 undefined	0.52 undefined	0.3 undefined
2019	2.1 undefined	0.48 undefined	0.38 undefined
2018	1.66 undefined	0.47 undefined	0.46 undefined
2017	1.41 undefined	0.44 undefined	0.35 undefined
2016	1.09 undefined	0.36 undefined	0.28 undefined
2015	0.73 undefined	0.2 undefined	0.23 undefined
2014	0.58 undefined	0.18 undefined	0.15 undefined
2013	0.45 undefined	0.1 undefined	0.05 undefined
2012	4.21 undefined	0.81 undefined	0.64 undefined
2011	3.45 undefined	0.77 undefined	0.69 undefined
2010	2.72 undefined	0.57 undefined	0.53 undefined
2009	2.1 undefined	0.56 undefined	0.55 undefined
2008	1.6 undefined	0.32 undefined	0.26 undefined
2007	1.23 undefined	0.34 undefined	0.56 undefined
2006	1.28 undefined	0.4 undefined	0.31 undefined
2005	1.02 undefined	0.24 undefined	0.16 undefined
2004	0.77 undefined	0.13 undefined	0.07 undefined

	Sales per Share	EBIT per share	Earnings per Share
2004	0.77 CNY	0.13 CNY	0.07 CNY
2005	1.02 CNY	0.24 CNY	0.16 CNY
2006	1.28 CNY	0.4 CNY	0.31 CNY
2007	1.23 CNY	0.34 CNY	0.56 CNY
2008	1.6 CNY	0.32 CNY	0.26 CNY
2009	2.1 CNY	0.56 CNY	0.55 CNY
2010	2.72 CNY	0.57 CNY	0.53 CNY
2011	3.45 CNY	0.77 CNY	0.69 CNY
2012	4.21 CNY	0.81 CNY	0.64 CNY
2013	0.45 CNY	0.1 CNY	0.05 CNY
2014	0.58 CNY	0.18 CNY	0.15 CNY
2015	0.73 CNY	0.2 CNY	0.23 CNY
2016	1.09 CNY	0.36 CNY	0.28 CNY
2017	1.41 CNY	0.44 CNY	0.35 CNY
2018	1.66 CNY	0.47 CNY	0.46 CNY
2019	2.1 CNY	0.48 CNY	0.38 CNY
2020	2.03 CNY	0.52 CNY	0.3 CNY
2021	2.3 CNY	0.64 CNY	0.6 CNY
2022	2.59 CNY	0.76 CNY	0.72 CNY
2023	3.2 CNY	1 CNY	0.63 CNY
2024e	3.75 CNY	0 CNY	0.82 CNY
2025e	4.06 CNY	0 CNY	0.89 CNY
2026e	4.42 CNY	0 CNY	0.94 CNY
2027e	4.55 CNY	0 CNY	0.58 CNY
2028e	5.21 CNY	0 CNY	0 CNY
2029e	5.61 CNY	0 CNY	0 CNY

	Number of stocks
2004	100 M Aktien
2005	100 M Aktien
2006	100 M Aktien
2007	146.7 M Aktien
2008	151.7 M Aktien
2009	151 M Aktien
2010	154.1 M Aktien
2011	157.1 M Aktien
2012	159 M Aktien
2013	1.94 B Aktien
2014	1.94 B Aktien
2015	2.3 B Aktien
2016	2.56 B Aktien
2017	2.65 B Aktien
2018	2.75 B Aktien
2019	2.54 B Aktien
2020	2.75 B Aktien
2021	2.77 B Aktien
2022	2.65 B Aktien
2023	2.44 B Aktien
2024e	2.44 B Aktien
2025e	2.44 B Aktien
2026e	2.44 B Aktien
2027e	2.44 B Aktien
2028e	2.44 B Aktien
2029e	2.44 B Aktien

Date	3SBio Dividend
2029e	0.11 undefined
2028e	0.11 undefined
2027e	0.11 undefined
2026e	0.11 undefined
2025e	0.11 undefined
2024e	0.11 undefined
2023	0.1 undefined
2022	0.2 undefined
2018	0.07 undefined

	Dividend	Dividend (Estimate)
2004	0 CNY	0 CNY
2005	0 CNY	0 CNY
2006	0 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0 CNY	0 CNY
2009	0 CNY	0 CNY
2010	0 CNY	0 CNY
2011	0 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0 CNY	0 CNY
2015	0 CNY	0 CNY
2016	0 CNY	0 CNY
2017	0 CNY	0 CNY
2018	0.07 CNY	0 CNY
2019	0 CNY	0 CNY
2020	0 CNY	0 CNY
2021	0 CNY	0 CNY
2022	0.2 CNY	0 CNY
2023	0.1 CNY	0 CNY
2024e	0 CNY	0.11 CNY
2025e	0 CNY	0.11 CNY
2026e	0 CNY	0.11 CNY
2027e	0 CNY	0.11 CNY
2028e	0 CNY	0.11 CNY
2029e	0 CNY	0.11 CNY

Date	3SBio Payout ratio
2029e	25.22 %
2028e	25.34 %
2027e	25.29 %
2026e	25.02 %
2025e	25.71 %
2024e	25.15 %
2023	24.2 %
2022	27.78 %
2021	23.48 %
2020	21.33 %
2019	21.33 %
2018	14.89 %
2017	21.33 %
2016	21.33 %
2015	21.33 %
2014	21.33 %
2013	21.33 %
2012	21.33 %
2011	21.33 %
2010	21.33 %
2009	21.33 %
2008	21.33 %
2007	21.33 %
2006	21.33 %
2005	21.33 %
2004	21.33 %

	Payout ratio
2004	21.33 %
2005	21.33 %
2006	21.33 %
2007	21.33 %
2008	21.33 %
2009	21.33 %
2010	21.33 %
2011	21.33 %
2012	21.33 %
2013	21.33 %
2014	21.33 %
2015	21.33 %
2016	21.33 %
2017	21.33 %
2018	14.89 %
2019	21.33 %
2020	21.33 %
2021	23.48 %
2022	27.78 %
2023	24.2 %
2024e	25.15 %
2025e	25.71 %
2026e	25.02 %
2027e	25.29 %
2028e	25.34 %
2029e	25.22 %

%	Name	Stocks	Change	Date
20.06253 %	Century Sunshine Ltd.	476,774,553	0	6/21/2023
2.48454 %	The Vanguard Group, Inc.	59,043,662	0	3/31/2024
2.11350 %	Lou (Jing)	50,226,063	0	6/21/2023
2.09805 %	BlackRock Institutional Trust Company, N.A.	49,859,065	-35,424,500	3/4/2024
1.47239 %	Medical Recovery Ltd.	34,990,480	0	12/31/2022
1.39915 %	Dimensional Fund Advisors, L.P.	33,250,000	11,500	2/29/2024
1.35486 %	Huang (Bin)	32,197,350	0	12/31/2022
1.31672 %	Bosera Asset Management Co., Ltd.	31,291,000	10,592,500	12/31/2023
1.11612 %	Bankinter Gestión de Activos, SGIIC S.A.	26,524,000	26,524,000	6/30/2023
1.11612 %	Bankinter, S.A. (Madrid)	26,524,000	0	12/31/2022
1.02610 %	Su (Dongmei)	24,384,630	0	12/31/2022
0.98704 %	GF Fund Management Co., Ltd.	23,456,500	14,108,000	12/31/2023
0.69688 %	Universal Vintage Ltd.	16,561,000	0	12/31/2022
0.66738 %	Norges Bank Investment Management (NBIM)	15,859,872	5,853,866	12/31/2023
0.46475 %	BlackRock Financial Management, Inc.	11,044,500	-1,083,500	11/27/2023
0.43763 %	Ninety One UK Limited	10,400,000	-845,000	12/31/2023
0.37335 %	China Asset Management Co., Ltd.	8,872,500	5,325,500	12/31/2023
0.37216 %	APG Asset Management N.V.	8,844,166	-4,205,422	9/30/2023
0.34150 %	Geode Capital Management, L.L.C.	8,115,500	193,500	2/29/2024
0.31052 %	BlackRock Investment Management (UK) Ltd.	7,379,286	-5,360,131	2/21/2024
0.30308 %	BlackRock Advisors (UK) Limited	7,202,500	153,000	3/31/2024
0.24116 %	Harvest Fund Management Co., Ltd.	5,731,000	5,731,000	12/31/2023
0.22975 %	BlackRock (Netherlands) B.V.	5,459,908	1,195,500	2/14/2024
0.22789 %	Baillie Gifford & Co.	5,415,716	0	1/31/2024
0.22375 %	California State Teachers Retirement System	5,317,249	-5,231,000	6/30/2023
0.21759 %	Dimensional Fund Advisors, Ltd.	5,171,000	-28,500	2/29/2024
0.19262 %	BlackRock Asset Management Ireland Limited	4,577,500	-17,705,500	3/4/2024
0.19213 %	State Street Global Advisors (UK) Ltd.	4,565,850	4	3/31/2024
0.19125 %	Royal London Asset Management Ltd.	4,545,000	0	12/31/2023
0.17173 %	Zürcher Kantonalbank (Asset Management)	4,081,000	-1,021,500	2/29/2024
0.17141 %	Nordea Investment Management AB (Denmark)	4,073,500	-6,941,000	2/29/2024
0.16876 %	INVESCO Great Wall Fund Management Co. Ltd.	4,010,500	747,000	12/31/2023
0.16624 %	E Fund Management Co. Ltd.	3,950,500	1,027,000	12/31/2023
0.16247 %	Macquarie Funds Management Hong Kong Ltd.	3,861,000	40,000	8/31/2022
0.15569 %	Royal London Asset Management (CIS) Limited_NLE	3,700,000	416,500	8/31/2023
0.15107 %	Jupiter Asset Management Ltd.	3,590,000	-2,541,500	12/31/2023
0.14233 %	Chang Xin Asset Management Co., Ltd.	3,382,500	3,382,500	12/31/2023
0.13338 %	Polunin Capital Partners Limited	3,169,784	-1,156,000	6/30/2023
0.13242 %	Numeric Investors LLC	3,146,780	670,433	2/29/2024
0.12100 %	American Century Investment Management, Inc.	2,875,500	0	3/31/2024
0.11926 %	State Street Global Advisors (US)	2,834,134	-285,890	3/31/2024
0.11728 %	HSBC JinTrust Fund Management Co., Ltd.	2,787,000	2,787,000	12/31/2023
0.11713 %	First Trust Advisors L.P.	2,783,508	-22,388	2/29/2024
0.11568 %	SEI Investments Management Corporation	2,749,077	172,701	3/31/2024
0.11561 %	MFS Investment Management	2,747,500	0	2/29/2024
0.11528 %	ICBC Credit Suisse Asset Management Co. Ltd.	2,739,500	150,000	12/31/2023
0.10535 %	Fullgoal Fund Management Co., Ltd.	2,503,500	1,547,000	12/31/2023
0.10299 %	Mellon Investments Corporation	2,447,500	-872,500	3/31/2024
0.10234 %	Charles Schwab Investment Management, Inc.	2,432,101	0	3/31/2024
0.10011 %	Vident Investment Advisory, LLC	2,379,000	0	3/31/2024
0.09022 %	Penghua Fund Management Co., Ltd.	2,144,000	327,000	12/31/2023
0.08231 %	HSBC Global Asset Management (UK) Limited	1,956,044	-135,560	2/29/2024
0.07934 %	Allianz Global Investors GmbH	1,885,383	-221,000	2/29/2024
0.07204 %	China Asset Management (Hong Kong) Limited	1,711,970	-102,000	3/31/2024
0.07202 %	Swedbank Robur Fonder AB	1,711,500	0	2/29/2024
0.07060 %	Northern Trust Global Investments Limited	1,677,852	-2,141,000	2/29/2024
0.06470 %	Russell Investments Limited	1,537,600	0	2/29/2024
0.06207 %	Pictet Asset Management Ltd.	1,475,000	-112,500	12/31/2023
0.06160 %	PGGM Vermogensbeheer B.V.	1,463,892	442,075	7/31/2023
0.05944 %	PensionDanmark A/S	1,412,472	1,412,472	8/31/2023
0.05808 %	RAM Active Investments S.A.	1,380,126	-1,358,874	12/31/2023
0.05639 %	Amundi Japan Ltd.	1,340,000	-579,000	3/31/2024
0.05329 %	Nuveen LLC	1,266,500	-176,254	3/31/2024
0.05146 %	China Southern Asset Management Co. Ltd.	1,223,000	393,000	12/31/2023
0.05069 %	Storebrand Kapitalforvaltning AS	1,204,500	52,000	2/29/2024
0.04959 %	State Street Global Advisors (Japan) Co., Ltd.	1,178,524	0	2/29/2024
0.04713 %	Yinhua Fund Management Co., Ltd.	1,120,000	851,500	12/31/2023
0.04250 %	Goldman Sachs Advisors B.V._NLE	1,010,000	0	11/30/2023
0.04248 %	Franklin Advisers, Inc.	1,009,500	68,000	3/31/2024
0.04214 %	Irish Life Investment Managers Ltd.	1,001,500	0	2/29/2024
0.04202 %	AQR Capital Management, LLC	998,500	-504,500	12/31/2023
0.04014 %	OP Varainhoito Oy	953,869	0	2/29/2024
0.03953 %	KLP Fondsforvaltning AS	939,300	0	2/29/2024
0.03655 %	Parametric Portfolio Associates LLC	868,500	0	1/31/2024
0.03472 %	Robeco Institutional Asset Management B.V.	825,092	0	3/31/2024
0.03333 %	BlackRock Asset Management North Asia Limited	792,000	37,500	12/31/2023
0.03219 %	Degroof Petercam Asset Management	764,914	-126,000	12/31/2023
0.02969 %	BMO Asset Management Inc.	705,508	0	3/31/2024
0.02870 %	Lazard Asset Management, L.L.C.	682,050	-59,000	12/31/2023
0.02674 %	Grantham Mayo Van Otterloo & Co LLC	635,500	-324,500	11/30/2023
0.02569 %	Legal & General Investment Management Ltd.	610,500	-330,000	2/29/2024
0.02504 %	HFT Investment Management Co., Ltd.	595,082	214,000	12/31/2023
0.02500 %	British Columbia Investment Management Corp.	594,193	55,660	3/31/2023
0.02428 %	KEPLER-FONDS Kapitalanlagegesellschaft m.b.H.	577,000	-31,000	2/29/2024
0.02094 %	Neuberger Berman, LLC	497,592	0	5/31/2023
0.02066 %	Goldman Sachs Asset Management, L.P.	490,989	-3,832	3/31/2024
0.02062 %	Bellevue Asset Management AG	490,000	173,000	6/30/2023
0.01992 %	Guotai Asset Management Co., Ltd.	473,351	266,638	12/31/2023
0.01828 %	BNP Paribas Asset Management France SAS	434,500	231,000	2/29/2024
0.01814 %	Northern Trust Investments, Inc.	431,000	0	3/31/2024
0.01736 %	Tianhong Asset Management Co., Ltd.	412,500	110,000	6/30/2023
0.01736 %	DFA Australia Ltd.	412,495	54,995	12/31/2023
0.01631 %	Eurizon Capital S.A.	387,659	-337,623	2/29/2024
0.01628 %	Huatai-PineBridge Fund Management Co., Ltd.	387,000	247,000	12/31/2023
0.01626 %	State Street Global Advisors Ireland Limited	386,500	-31,800	3/31/2024
0.01620 %	China Universal Asset Management Co., Ltd.	385,000	156,500	12/31/2023
0.01603 %	BlackRock Advisors, LLC	381,000	0	10/31/2023
0.01549 %	Tibet Eastmoney Fund Management Co., Ltd.	368,000	368,000	12/31/2023
0.01546 %	AXA Investment Managers Asia Limited	367,500	0	2/29/2024
0.01530 %	OLZ AG	363,500	20,500	10/31/2023

What values and corporate philosophy does 3SBio represent?

3SBio Inc represents a commitment to innovation, integrity, and excellence in the biopharmaceutical industry. The company values putting patients first and developing high-quality therapeutic solutions. With a focus on research and development, 3SBio Inc is dedicated to discovering, developing, and commercializing innovative biopharmaceutical products. The company's corporate philosophy centers around offering effective and affordable treatments to improve patients' lives. By staying true to their core values, 3SBio Inc aims to make a positive impact on healthcare and contribute to the well-being of individuals worldwide.

In which countries and regions is 3SBio primarily present?

3SBio Inc is primarily present in China and the United States.

What significant milestones has the company 3SBio achieved?

3SBio Inc has achieved several significant milestones. The company successfully completed its initial public offering (IPO) on the Hong Kong Stock Exchange in 2015, marking a major milestone in its history. Furthermore, 3SBio Inc has seen remarkable growth and success in the biopharmaceutical industry, particularly in the development and commercialization of innovative medicines. They have obtained regulatory approvals for various products, expanded their product portfolio, and established strategic partnerships to enhance their market presence. The company's dedication to research and development has also resulted in numerous scientific achievements and breakthroughs. Overall, 3SBio Inc has demonstrated consistent progress and remains a leading player in the biopharmaceutical sector.

What is the history and background of the company 3SBio?

3SBio Inc is a leading biotechnology company specializing in the research, development, and manufacturing of innovative biopharmaceutical products. Founded in 1993, the company has a rich history in the biotech industry. With its headquarters in China, 3SBio Inc has expanded globally and gained recognition for its expertise in therapeutic areas including nephrology, oncology, and immunology. The company is committed to improving patient outcomes through the development of high-quality, life-saving medications. 3SBio Inc has established itself as a trusted name in the biopharmaceutical sector, delivering innovative solutions to address unmet medical needs and improve the quality of life for patients worldwide.

Who are the main competitors of 3SBio in the market?

The main competitors of 3SBio Inc in the market include companies such as Johnson & Johnson, Pfizer Inc, Novartis International AG, Amgen Inc, and Roche Holding AG.

In which industries is 3SBio primarily active?

3SBio Inc is primarily active in the biotechnology and pharmaceutical industries.

What is the business model of 3SBio?

3SBio Inc operates as a leading biotechnology company. The business model of 3SBio Inc revolves around the research, development, manufacturing, and commercialization of biopharmaceutical products. The company focuses on developing innovative therapies to address unmet medical needs, particularly in the fields of oncology, nephrology, and autoimmune diseases. By leveraging their expertise in biologics and in-house manufacturing capabilities, 3SBio Inc aims to deliver high-quality and affordable medicines to patients worldwide. With a commitment to advancing healthcare, 3SBio Inc continues to invest in R&D efforts and strategic partnerships, aiming to improve patient outcomes and enhance their market presence.

What is the P/E ratio of 3SBio 2024?

The 3SBio P/E ratio is 6.53.

What is the P/S ratio of 3SBio 2024?

The 3SBio P/S ratio is 1.42.

What is the AlleAktien quality score of 3SBio?

The AlleAktien quality score for 3SBio is 8/10.

What is the revenue of 3SBio 2024?

The expected 3SBio revenue is 8.92 B CNY.

How high is the profit of 3SBio 2024?

The expected 3SBio profit is 1.95 B CNY.

What is the business model of 3SBio

The Chinese company 3SBio Inc is a leading company in the biopharmaceutical industry, specializing in the development, manufacturing, and marketing of biological drugs. 3SBio focuses on the areas of oncology, immunology, nephrology, and infectious diseases. The main products of 3SBio include biosimilars of innovative drugs such as rituximab, enoxaparin, adalimumab, darbepoetin alfa, pegaspargase, and etanercept. Biosimilars are biologically manufactured drugs that have similar active ingredients as original biologics and thus provide a more cost-effective alternative. 3SBio has the largest market share for biosimilars in China and continually expands its portfolio. In addition to biosimilars, 3SBio also offers innovative biological drugs. One example is Tpiao, a recombinant human thrombopoietin receptor agonist. It is used to treat thrombocytopenia in patients with hepatitis B or hepatitis C infections. Another important area for 3SBio is nephrology. The company has various products in its portfolio that are used to treat kidney diseases. These include, for example, the erythropoiesis-stimulating agent (ESA) ferumoxytol, which is used to treat iron deficiency anemia in chronic kidney disease, as well as binodenoson, an adenosine receptor agonist used for diagnostic imaging of kidney diseases. The business model of 3SBio Inc is based on the acquisition of promising technologies, its own research and development work, and the manufacturing and marketing of biological drugs. The company works closely with regulatory authorities and health organizations to achieve fast market approval for its products. An important aspect is also international distribution. 3SBio strategically enters growth markets in Asia, especially in China, and expands into other parts of the world. Through partnerships with other companies and the acquisition of firms in the biopharmaceutical industry, 3SBio continuously expands its value chain and its portfolio. Overall, 3SBio pursues a diversified business model based on the utilization of synergies in the areas of research, development, manufacturing, and marketing of biological drugs. By utilizing biosimilars and innovative active ingredients, the company has achieved high competitiveness and is on a path of expansion.

What is the 3SBio dividend?

3SBio pays a dividend of 0.2 CNY distributed over payouts per year.

How often does 3SBio pay dividends?

The dividend cannot currently be calculated for 3SBio or the company does not pay out a dividend.

What is the 3SBio ISIN?

The ISIN of 3SBio is KYG8875G1029.

What is the 3SBio WKN?

The WKN of 3SBio is A14T7Q.

What is the 3SBio ticker?

The ticker of 3SBio is 1530.HK.

How much dividend does 3SBio pay?

Over the past 12 months, 3SBio paid a dividend of 0.1 CNY . This corresponds to a dividend yield of about 1.92 %. For the coming 12 months, 3SBio is expected to pay a dividend of 0.11 CNY.

What is the dividend yield of 3SBio?

The current dividend yield of 3SBio is 1.92 %.

When does 3SBio pay dividends?

3SBio pays a quarterly dividend. This is distributed in the months of July, July, July, August.

How secure is the dividend of 3SBio?

3SBio paid dividends every year for the past 0 years.

What is the dividend of 3SBio?

For the upcoming 12 months, dividends amounting to 0.11 CNY are expected. This corresponds to a dividend yield of 2.13 %.

In which sector is 3SBio located?

3SBio is assigned to the 'Health' sector.

Wann musste ich die Aktien von 3SBio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 3SBio from 8/5/2024 amounting to 0.25 CNY, you needed to have the stock in your portfolio before the ex-date on 7/22/2024.

When did 3SBio pay the last dividend?

The last dividend was paid out on 8/5/2024.

What was the dividend of 3SBio in the year 2023?

In the year 2023, 3SBio distributed 0.2 CNY as dividends.

In which currency does 3SBio pay out the dividend?

The dividends of 3SBio are distributed in CNY.

Scope 1 - Direct Emissions	728,600
Scope 2 - Indirect emissions from purchased energy	206,807
Scope 3 - Indirect emissions within the value chain	23,567,680
Total CO₂ emissions	935,407
CO₂ reduction strategy	✅
Coal energy	✅
Nuclear power	❌
Animal experiments	❌
Fur & Leather	—
Pesticides	✅
Palm Oil	—
Tobacco	❌
Genetically modified organisms	❌
Climate concept	—
Sustainable forestry	—
Recycling regulations	✅
Environmentally friendly packaging	❌
Hazardous substances	❌
Fuel consumption and efficiency	❌
Water consumption and efficiency	✅

Percentage of female employees	—
Percentage of women in management	—
Percentage of Asian employees	—
Share of Asian management	—
Percentage of Hispanic/Latino employees	—
Hispano/Latino Management share	—
Percentage of Black employees	—
Black Management Share	—
Percentage of white employees	—
White Management Share	—
Adult content	❌
Alcohol	❌
Weapons	—
Firearms	❌
Gambling	❌
Military contracts	❌
Human rights concept	✅
Privacy concept	—
Occupational health and safety	✅
Catholic	✅

Environmental reporting	✅
Stakeholder Engagement	✅
Call Back Policies	❌
Antitrust law	❌

Stock Exchange	3SBio Ticker
DÜSSELDORF	83B.DU
FRANKFURT	83B.F
HKSE	1530.HK
MUNICH	83B.MU
PNK	TRSBF

3SBio Ticker	3SBio FIGI
83B:GM	BBG009CK4GD8
83B:GB	BBG009CK4GF6
83B:TH	BBG009CVMW94
1530EUR:XG	BBG00CTTKM98
1530EUR:XO	BBG00CTTKMB5
1530:HK	BBG009BKGLS9
83B:GR	BBG009CK4G75
83B:GF	BBG009CK4G84
83B:GD	BBG009CK4G93
83B:GS	BBG009CK4GC9
1530:H1	BBG00B623T70
83B:QT	BBG00CTTGG23
1530EUR:EO	BBG00CTTKLZ1
1530EUR:XH	BBG00CTTKM25
1530EUR:XF	BBG00CTTKM43
1530EUR:XE	BBG00CTTKM61
1530EUR:XJ	BBG00CTTKM70
1530EUR:XL	BBG00CTTKM89
1530EUR:XS	BBG00CTTKMG0
1530EUR:XA	BBG00CTTKMH9
1530EUR:E1	BBG00CTTKMJ7
1530EUR:XT	BBG00CTTKMK5
1530EUR:XW	BBG00CTTKML4
1530EUR:XU	BBG00CTTKMM3
1530EUR:XV	BBG00CTTKMN2
1530EUR:EU	BBG00CTTKMQ9
1530:H2	BBG00F135N75
1530EUR:XX	BBG00JN8HFD9
1530HKD:X2	BBG00JPVMFC1
1530HKD:XB	BBG00JPVMFD0
1530HKD:XH	BBG00JPVMFG7
1530HKD:XF	BBG00JPVMFJ4
1530HKD:XE	BBG00JPVMFL1
1530HKD:XJ	BBG00JPVMFM0
1530HKD:XL	BBG00JPVMFN9
1530HKD:XG	BBG00JPVMFP7
1530HKD:XO	BBG00JPVMFQ6
1530HKD:XS	BBG00JPVMFV0
1530HKD:XA	BBG00JPVMFW9
1530HKD:E1	BBG00JPVMFX8
1530HKD:XT	BBG00JPVMFY7
1530HKD:XW	BBG00JPVMFZ6
1530HKD:XU	BBG00JPVMG02
1530HKD:XV	BBG00JPVMG11
1530HKD:XM	BBG00JPVMG20
1530HKD:XQ	BBG00JPVMG48
1530HKD:XX	BBG00JPVMG57
1530HKD:XZ	BBG00JPVMG66
1530HKD:EU	BBG00JPVMG93
1530N:PO	BBG00JRF8MX2
1530N:L3	BBG00JRFC993
1530N:B3	BBG00JRFF160
TRSBF:US	BBG00L5DRY23
TRSBF:PQ	BBG00L5DRYL2
TRSBF:UV	BBG00L5DRYM1
1530N:L1	BBG00Y7B1225
83B:LA	BBG018H9DRT8
83B:LU	BBG018J31SL8
83B:GZ	BBG01K0TCGL8

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

3SBio stock price, quote, forecast and news stock price, forecast, news, chart, split, dividend and analysis 3SBio ariva, 3SBio onvista, 3SBio finanzen.net, 3SBio aktienfinder, 3SBio marketscreener, 3SBio marketwatch, 3SBio bloomberg, 3SBio handelsblatt, 3SBio wiwo, 3SBio forum

Price

Price

Ticker1530.HK

ISINKYG8875G1029

WKNA14T7Q

3SBio stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

3SBio Stock Price History

3SBio Revenue, EBIT, Net Income KYG8875G1029 · A14T7Q

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

3SBio Revenue, EBIT and net profit per share

3SBio Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

3SBio stock margins KYG8875G1029 · A14T7Q

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

3SBio Margin History

3SBio Stock Sales Revenue, EBIT, Earnings per Share KYG8875G1029 · A14T7Q

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

3SBio Revenue, EBIT and net profit per share

3SBio business model

3SBio SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

3SBio Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

3SBio historical P/E ratio, EBIT, and P/S ratio.

3SBio shares outstanding KYG8875G1029 · A14T7Q

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

3SBio dividend history and estimates KYG8875G1029 · A14T7Q

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

3SBio Dividend History

3SBio dividend payout ratio KYG8875G1029 · A14T7Q

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

3SBio stock price, quote, forecast and news
stock price, forecast, news, chart, split, dividend and analysis 3SBio ariva, 3SBio onvista, 3SBio finanzen.net, 3SBio aktienfinder, 3SBio marketscreener, 3SBio marketwatch, 3SBio bloomberg, 3SBio handelsblatt, 3SBio wiwo, 3SBio forum

Ticker
1530.HK

ISIN
KYG8875G1029

WKN
A14T7Q